China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
Release time：2024-05-01 11:30:14 Source：Earthly Edition news portal
-
Contact Us
- Home
- News
- People
- In-depth
- ACWF
- 2023 Women Science and Technology Innovation Pioneer...
- People Enjoy Blooming Tulips in Jinan, East...
- Flowers Bloom Across China in Spring
China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
September 1, 2022 |
| A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. [Xinhua/Xiong Qi] |
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV).
A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent.
Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases.
The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study.
Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
Comments
Magazines
Projects
Photos
Special Coverage
- Previous：Alabama lawmakers propose compromise on gambling bill with lottery, electronic wagering machines
- Next：The US is building a pier off Gaza to bring in humanitarian aid. Here's how it would work
Related articles
- Travis Kelce agrees to new TWO
- Green Rural Revival Program Lifts Image of Countryside in China's Zhejiang
- Hangzhou Asiad Medal Design Unveiled with 100 Days to Go
- China Int'l Big Data Expo Attracts Youngsters
- The Valley's Jesse Lally steps out with stunning new girlfriend Lacy Nicole
- China Moves to Strengthen Scientific Education in Primary, Secondary Schools
- Tourism Booms Across China As 5
- Marriage Registrations Fall to Record Low in China
- Lottery bids for skilled
- China Enhances Judicial Protection for Minors Against Sexual Violations
- Eric Church DOUBLES DOWN on Stagecoach gospel headlining set
- China Focus: PLA Navy's Founding Anniversary Commemorated with Public Celebrations
- Village Basketball Competition Kicks off in SW China's Guizhou
- E China's Datang Subdistrict of Zhuji, Largest Hosiery Production Base in World
- 2 men are charged with cutting down famous 150
- China's Top Procuratorate Promotes Law's Implementation
- Hangzhou Asiad Medal Design Unveiled with 100 Days to Go
- China Int'l Big Data Expo Attracts Youngsters
- California's population grew in 2023, halting 3 years of decline
- Spring Bud Girls Receive Gifts ahead of Int'l Children's Day
Random recommendation
- Copyright © 2024 Powered by China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial ,Earthly Edition news portal sitemap